A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/2009
12/10/2009	US20090304713 Binding agents
12/10/2009	US20090304712 Neuronal Cell Death Inhibitor and Screening Method
12/10/2009	US20090304711 Combinatorial Therapy of Cancer and Infectious Diseases with Anti-B7-H1 Antibodies
12/10/2009	US20090304710 Novel anti-cd38 antibodies for the treatment of cancer
12/10/2009	US20090304709 Modulators of p-selectin glycoprotein ligand 1
12/10/2009	US20090304708 Preparation for the Prevention and/or Treatment of a Tissue Change of Mesenchymal Origin
12/10/2009	US20090304707 Monoclonal antibodies to basic fibroblast growth factor
12/10/2009	US20090304706 Antagonist anti-cd40 antibody pharmaceutical compositions
12/10/2009	US20090304705 Biomarkers for chronic transplant dysfunction
12/10/2009	US20090304704 Methods for diagnosing and predicting non-alcoholic steatohepatitis (nash)
12/10/2009	US20090304703 Compositions and methods for the diagnosis and treatment of immune disorders
12/10/2009	US20090304702 Gene expressed in prostate cancer and methods of use
12/10/2009	US20090304701 Antibodies binding il-1 related polypeptides
12/10/2009	US20090304700 Conformation specific antibodies that bind trefoil factors
12/10/2009	US20090304699 Methods of treating fibrosis
12/10/2009	US20090304698 Modulation of ovulation
12/10/2009	US20090304697 Identification and use of prognostic and predictive markers in cancer treatment
12/10/2009	US20090304696 Single Chain FC Polypeptides
12/10/2009	US20090304695 Methods for treating cancer by inhibiting wnt signaling
12/10/2009	US20090304694 Ang2 and Vegf Inhibitor Combinations
12/10/2009	US20090304693 Dual Variable Domain Immunoglobulins and Uses Thereof
12/10/2009	US20090304692 Triazine compounds as pi3 kinase and mtor inhibitors
12/10/2009	US20090304691 Antagonists of bmp9, bmp10, alk1 and other alk1 ligands, and uses thereof
12/10/2009	US20090304690 Glycosylation Engineering of Antibodies for Improving Antibody-Dependent Cellular Cytotoxicity
12/10/2009	US20090304689 Methods for the identification of polypeptide antigens associated with disorders involving aberrant cell proliferation and compositions useful for the treatment of such disorders
12/10/2009	US20090304688 Methods and Compositions for Increasing the Efficiency of Therapeutic Antibodies Using Gamma Delta T Cell Activators
12/10/2009	US20090304687 Methods of using cd40 binding agents
12/10/2009	US20090304686 Interfering in activation of an immune cell by influencing interaction of lair and collagen
12/10/2009	US20090304685 Anti-Factor Xlla Therapy
12/10/2009	US20090304684 Methods and compositions for needleless delivery of antibodies
12/10/2009	US20090304683 Soluble Fragments of The Sars-Cov Spike Glycoprotein
12/10/2009	US20090304682 Multiple-variable dose regimen for treating TNFa-related disorders
12/10/2009	US20090304681 Methods for the treatment and prevention of infection using anti-selectin agents
12/10/2009	US20090304680 Diagnosis and treatment of kawasaki disease
12/10/2009	US20090304679 Antibodies as T cell receptor mimics, methods of production and uses thereof
12/10/2009	US20090304678 Means for Inhibiting the Expression of Protein Kinase 3
12/10/2009	US20090304677 Extracorporeal Removal of Microvesicular Particles
12/10/2009	US20090304676 Compositions and methods for enhancing cognitive function
12/10/2009	US20090304675 Method of modulation of mullerian inhibitory substance (mis) receptor for the treatment of neurodegenerative diseases
12/10/2009	US20090304674 Methods for treating disease by regulating cll cell survival
12/10/2009	US20090304631 Hepatitis c serine protease inhibitors and uses therefor
12/10/2009	US20090304627 Smallpox dna vaccine and the antigens therein that elicit an immune response
12/10/2009	US20090304625 Modulators of cardiac cell hypertrophy and hyperplasia
12/10/2009	US20090304583 Pathological tissue detection and treatment employing targeted benzoindole optical agents
12/10/2009	US20090304580 Anti-Pancreatic Cancer Antibodies
12/10/2009	US20090304579 Cancerous Disease Modifying Antibodies
12/10/2009	US20090304578 Cancerous Disease Modifying Antibodies
12/10/2009	US20090304577 Peptides for Treatment and Diagnosis of Autoimmune Disease
12/10/2009	US20090304575 In vitro method for identifying compounds for cancer therapy
12/10/2009	DE19612966B4 MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren MDCK cells and methods for the propagation of influenza virus
12/10/2009	CA2728772A1 Anti-cd8 antibodies block priming of cytotoxic effectors and lead to generation of regulatory cd8+t cells
12/10/2009	CA2728423A1 Respiratory syncytial virus renders dendritic cells tolerogenic
12/10/2009	CA2728243A1 Neuroinvasion inhibitor
12/10/2009	CA2727171A1 Methods for the treatment of rheumatoid arthritis
12/10/2009	CA2726985A1 Small molecule inhibitors for the treatment or prevention of dengue virus infection
12/10/2009	CA2726914A1 A vaccine for the prevention and therapy of hcv infections
12/10/2009	CA2726817A1 Identification and use of prognostic and predictive markers in cancer treatment
12/10/2009	CA2726652A1 Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases
12/10/2009	CA2726511A1 Anti-inflammatory agents
12/10/2009	CA2726345A1 Interleukin-1 alpha abs and methods of use
12/10/2009	CA2725666A1 Dual variable domain immunoglobulins and uses thereof
12/10/2009	CA2725361A1 Coccidiosis vaccines
12/10/2009	CA2723999A1 Pestivirus replicons providing an rna-based viral vector system
12/10/2009	CA2723918A1 Compositions comprising liposomes, an antigen, a polynucleotide and a carrier comprising a continuous phase of a hydrophobic substance
12/09/2009	EP2131198A2 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays
12/09/2009	EP2130921A2 Vaccine for prevention and treatment of HIV-infection
12/09/2009	EP2130920A2 Beta-like glycoprotein hormone polypeptide and heterodimer
12/09/2009	EP2130912A1 Pestivirus replicons providing an RNA-based viral vector system
12/09/2009	EP2130552A1 Pharmaceutical composition comprising anti-grp78 antibody as active ingredient
12/09/2009	EP2130547A1 IL-25 for use in the treatment of inflammatory diseases
12/09/2009	EP2129773A2 Therapeutic applications of activation of human antigen-presenting cells through dectin-1
12/09/2009	EP2129693A2 Shortened purification process for the production of capsularstreptococcus pneumoniae polysaccharides
12/09/2009	EP2129690A1 Engineered anti-tslp antibody
12/09/2009	EP2129684A1 Method of purification of hydrophobic proteins
12/09/2009	EP2129401A2 Stable buffered formulations containing polypeptides
12/09/2009	EP2129399A1 Fxdy5 modulators for treating, diagnosing, and detecting cancer
12/09/2009	EP2129397A2 Methods and compositions for treating tumor diseases
12/09/2009	EP2129396A2 Antibodies against erbb3 and uses thereof
12/09/2009	EP2129392A2 Methods of vaccine administration
12/09/2009	EP2129391A1 Diagnostic method
12/09/2009	EP2129390A2 Turkey herpesvirus vectored recombinant containing avian influenza genes
12/09/2009	EP2129389A2 A method for enhancing t cell response
12/09/2009	EP2129366A2 Solid pharmaceutical and vaccine dose
12/09/2009	EP1732648B1 Treatment of diseases
12/09/2009	EP1706141B1 Methods of using botulinum toxin for the treatment of hypervolemic lip deformity (lip ectropion)
12/09/2009	EP1694707B1 Human anti-idiotypic antibody fragments that mimic her-2/neu
12/09/2009	EP1651264B1 Subunit vaccine against respiratory syncytial virus infection
12/09/2009	EP1458754B1 Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control
12/09/2009	EP1404368B1 Mutant forms of cholera holotoxin as an adjuvant
12/09/2009	EP1129110B1 Platelet-derived growth factor d, dna coding therefor, and uses thereof
12/09/2009	EP0959905B1 Polysaccharide-peptide-conjugates
12/09/2009	EP0912724B1 Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences
12/09/2009	CN101600459A Multivalent pneumococcal polysaccharide-protein conjugate composition
12/09/2009	CN101600457A Anti-IL-13 antibody formulations and uses thereof
12/09/2009	CN101600456A Methods and compositions for treating and monitoring treatment of IL-13-associated disorders
12/09/2009	CN101600455A Prophylactic tuberculosis vaccine
12/09/2009	CN101600454A Carbohydrate specific cellular immunity inducing microorganisms and fractions thereof
12/09/2009	CN101600453A Multicomponent vaccine
12/09/2009	CN101600450A Treatment of demyelinating disorders
12/09/2009	CN101597595A Bi-functional monoclonal antibody capable of anti-human von willbrand factor-A3

1 ... 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 ... 1823